Latest News about Biotech
Recent news which mentions Biotech
Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday?
February 21, 2025
From Benzinga
FDA Approves Mirum Pharmaceuticals' Drug As First For Genetic Disorder With Inability To Break-Down Cholesterol
February 21, 2025
From Benzinga
Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes
February 21, 2025
From Benzinga
As Covid Drug Cash Dwindles, Vigonvita Targets New Remedies
February 21, 2025
From Benzinga
European Addiction-Focused Indivior Stock Falls As Drugmaker Warns Lower Revenues In 2025 Despite Q4 Earnings Beat
February 20, 2025
From Benzinga
Why Is Penny Stock Aptose Biosciences Trading Higher On Thursday?
February 20, 2025
From Benzinga
Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million
February 20, 2025
From Benzinga
Why Is BioMarin Stock Trading Higher On Thursday?
February 20, 2025
From Benzinga
Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer
February 19, 2025
From Benzinga
Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate
February 19, 2025
From Benzinga
Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder
February 19, 2025
From Benzinga
Ionis Pharmaceuticals Q4 Revenue Growth Exceeds Guidance, Forecasts Over $600 Million In 2025 Sales
February 19, 2025
From Benzinga
Supernus Pharmaceuticals Stock Falls On Disappointing Data From Treatment-Resistant Depression Trial
February 19, 2025
From Benzinga
Novo Nordisk Sues Singapore-Based KBP Biosciences Over Alleged Data Misrepresentation In $1.3 Billion Hypertension Drug Deal, Seeks Damages
February 19, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.